Human Language Understanding & Reasoning Christopher D. Manning Christopher D. Manning Christopher D. Manning is the Thomas M. Siebel Professor in Machine Learning and Professor of Linguistics and of Computer Science at Stanford University; Director of the
2025-06-13
In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast
2025-06-08
The Electronic Frontier Foundation if Kapor wins,
or The Kurzweil Foundation if Kurzweil wins.
Kapor's Argument
The essence of the Turing Test revolves around whether
2025-06-01
Artificial Intelligence (AI) is an undisputed skill of the future. There are clear estimations that by 2030, the AI market will contribute more than $15 trillion to the world economy. We are seeing artificial intelligence in a myriad of applications across
2025-05-21
In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast
2025-05-20
When most people think of blockchain, they think financial transactions. While crypto and tokens garner the lion’s share of news, blockchain, and in particular smart contracts and more recent Web3 innovations, are becoming an indispensable part of the
2025-05-01
Artificial neural networks are famously inspired by their biological counterparts. Yet compared to human brains, these algorithms are highly simplified, even “cartoonish.” Can they teach us anything about how the brain works? For a panel at the Society
2025-04-21
In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast
2025-04-03
In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast
2025-03-23
